Parker Waichman LLP Headlines by Topic
Avandia
Settlements Reported in 20,000 Avandia Heart Attack Lawwsuits
Feb 2, 2012
| Parker Waichman LLP
GlaxoSmithKline has reportedly agreed to settle more than 20,000 Avandia heart attack lawsuits, according to a report from Bloomberg News. The...
Avandia, Actos Study Sees Higher Risk of Diabetic Macular Edema
Jun 28, 2011
| Parker Waichman LLP
People taking the diabetes medications Actos or Avandia have yet another side effect to worry about - a potentially blinding eye disorder called...
Avandia Curbs Will be in Effect by November, FDA Says
May 19, 2011
| Parker Waichman LLP
The U.S. Food & Drug Administration (FDA) has finally announced how and when it will implement new restrictions for Avandia and other diabetes...
1,000 Avandia Settlements in the Works
May 5, 2011
| Parker Waichman LLP
Momentum appears to be building towards more Avandia lawsuit settlements. Bloomberg News is reporting that GlaxoSmithKline, maker of the...
Avandia Black Box Warning Wasn't Heeded by All Doctors, Study Finds
Nov 18, 2010
| Parker Waichman LLP
Not all doctors are heeding warnings for Avandia. According to a study published in The New England Journal of Medicine that used Avandia as an...
Avandia Faces Justice Department Probe
Oct 22, 2010
| Parker Waichman LLP
Avandia, GlaxoSmithKline’s controversial diabetes drug, is coming under more scrutiny. According to a Wall Street Journal report, the drug...
Avandia, Bisphosphonate Problems Point to Weaknesses in Drug Approval Process
Oct 18, 2010
| Parker Waichman LLP
Recent safety issues involving the diabetes drug Avandia and a class of bone drugs called bisphosphonates have some questioning the way drugs are...
GlaxoSmithKline Outlook Falls Following Avandia Restrictions
Sep 24, 2010
| Parker Waichman LLP
GlaxoSmithKline’s Avandia problems are expected to take a toll on the drug maker’s bottom line. According to a Reuters report, analysts...
Avandia Severely Restricted by FDA
Sep 23, 2010
| Parker Waichman LLP
Citing heart risks from Avandia, the US Food & Drug Administration (FDA) has decided to place severe restrictions on the controversial diabetes...
Study Sees Same Heart Risks Seen With Actos, Avandia
Aug 26, 2010
| Parker Waichman LLP
New research has added to the growing body of evidence linking Avandia and Actos to increased adverse health risks. This time, the issue is cardiac,...
Page 1/11 [first] [prev] 1 2 3 4 5 6 7 8 9 10 ... [next] [last]
